Biomark Diagnostics
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. Learn more
Launch date
Employees
Market cap
$16.7m
Enterprise valuation
$17m (Public information from Sep 2024)
Share price
CAD0.26 BUX.CN
Richmond British Columbia (HQ)
Authorizing premium user...